Pfizer COVID Vaccine Trial Shows Alarming Evidence of Pathogenic Priming in Older Adults
February 28, 2021 ICWA ALERT: Potential for Pathogenic Priming Confirmed. On January 19, 2021 the research article Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases was published in the journal Frontiers in Immunology. The authors stated: We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies
Pfizer COVID Vaccine Trial Shows Alarming Evidence of Pathogenic Priming in Older Adults Read More »

